On December 27, 2017, Bridget M. Rohde, Acting U.S. Attorney for the Eastern District of New York, announced that Evan Greebel had been convicted of one count of conspiracy to commit securities fraud and one count of conspiracy to commit wire fraud, following an 11-week trial before U.S. District Judge Kiyo A. Matsumoto.  At one time a partner at Katten Muchin Rosenman LLP, Greebel served as outside counsel to biopharmaceutical company Retrophin Inc.  In this position, he conspired with Retrophin CEO Martin Shkreli to control Retrophin’s stock price and trading volume from 2012 to 2014, through methods including concealing Retrophin’s beneficial ownership and filing false documents.  Greebel and Shkreli also conspired from 2011 to 2014 to use Retrophin assets in order to make payments to defrauded investors in Shkreli’s hedge funds.  U.S. v. Greebel, 15-CR-637 (E.D.N.Y.)

DOJ Press Release

Related Proceeding Post